Literature DB >> 30535779

EQ-5D-5L Valuation for the Malaysian Population.

Asrul Akmal Shafie1, Annushiah Vasan Thakumar2, Ching Jou Lim2, Nan Luo3, Kim Rand-Hendriksen4, Faridah Aryani Md Yusof5.   

Abstract

OBJECTIVES: The aim of this study was to develop an EQ-5D-5L value set reflecting the health preferences of the Malaysian adult population.
METHODS: Respondents were sampled with quotas for urbanicity, gender, age, and ethnicity to ensure representativeness of the Malaysian population. The study was conducted using a standardized protocol involving the EuroQol Valuation Technology (EQ-VT) computer-assisted interview system. Respondents were administered ten composite time trade-off (C-TTO) tasks and seven discrete choice experiment (DCE) tasks. Both linear main effects and constrained non-linear regression models of C-TTO-only data and hybrid models combining C-TTO and DCE data were explored to determine an efficient and informative model for value set prediction.
RESULTS: Data from 1125 respondents representative of the Malaysian population were included in the analysis. Logical consistency was present in all models tested. Using cross-validation, eight-parameter models for C-TTO only and C-TTO + DCE hybrid data displayed greater out-of-sample predictive accuracy than their 20-parameter, main-effect counterparts. The hybrid eight-parameter model was chosen to represent the Malaysian value set, as it displayed greater out-of-sample predictive accuracy over C-TTO data than the C-TTO-only model, and produced more precise estimates. The estimated value set ranged from - 0.442 to 1.
CONCLUSIONS: The constrained eight-parameter hybrid model demonstrated the best potential in representing the Malaysian value set. The presence of the Malaysian EQ-5D-5L value set will facilitate its application in research and health technology assessment activities.

Entities:  

Mesh:

Year:  2019        PMID: 30535779     DOI: 10.1007/s40273-018-0758-7

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  25 in total

Review 1.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

Review 2.  International comparisons in valuing EQ-5D health states: a review and analysis.

Authors:  Richard Norman; Paula Cronin; Rosalie Viney; Madeleine King; Deborah Street; Julie Ratcliffe
Journal:  Value Health       Date:  2009-08-20       Impact factor: 5.725

3.  Estimating an EQ-5D-5L Value Set for China.

Authors:  Nan Luo; Gordon Liu; Minghui Li; Haijing Guan; Xuejing Jin; Kim Rand-Hendriksen
Journal:  Value Health       Date:  2017-02-09       Impact factor: 5.725

4.  Quality Control Process for EQ-5D-5L Valuation Studies.

Authors:  Juan M Ramos-Goñi; Mark Oppe; Bernhard Slaap; Jan J V Busschbach; Elly Stolk
Journal:  Value Health       Date:  2016-12-22       Impact factor: 5.725

5.  The EQ-5D-5L Valuation study in Thailand.

Authors:  Juntana Pattanaphesaj; Montarat Thavorncharoensap; Juan Manuel Ramos-Goñi; Sirinart Tongsiri; Lily Ingsrisawang; Yot Teerawattananon
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2018-07-06       Impact factor: 2.217

6.  Discrete choice modeling for the quantification of health states: the case of the EQ-5D.

Authors:  Elly A Stolk; Mark Oppe; Luciana Scalone; Paul F M Krabbe
Journal:  Value Health       Date:  2010-09-03       Impact factor: 5.725

7.  The Indonesian EQ-5D-5L Value Set.

Authors:  Fredrick Dermawan Purba; Joke A M Hunfeld; Aulia Iskandarsyah; Titi Sahidah Fitriana; Sawitri Supardi Sadarjoen; Juan Manuel Ramos-Goñi; Jan Passchier; Jan J V Busschbach
Journal:  Pharmacoeconomics       Date:  2017-11       Impact factor: 4.981

8.  Valuing health-related quality of life: An EQ-5D-5L value set for England.

Authors:  Nancy J Devlin; Koonal K Shah; Yan Feng; Brendan Mulhern; Ben van Hout
Journal:  Health Econ       Date:  2017-08-22       Impact factor: 3.046

9.  A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada.

Authors:  Feng Xie; Eleanor Pullenayegum; Kathy Gaebel; Nick Bansback; Stirling Bryan; Arto Ohinmaa; Lise Poissant; Jeffrey A Johnson
Journal:  Med Care       Date:  2016-01       Impact factor: 2.983

10.  Assessing the Use of a Feedback Module to Model EQ-5D-5L Health States Values in Hong Kong.

Authors:  Eliza L Y Wong; Juan Manuel Ramos-Goñi; Annie W L Cheung; Amy Y K Wong; Oliver Rivero-Arias
Journal:  Patient       Date:  2018-04       Impact factor: 3.883

View more
  23 in total

1.  Health-related quality of life using EQ-5D among chronic myeloid leukaemia patients in health centres in Klang Valley, Malaysia.

Authors:  Sharifa Ezat Wan Puteh; Azimatun Noor Aizuddin; Nor Rafeah Tumian; Jameela Sathar; Ellyana Mohamad Selamat
Journal:  PLoS One       Date:  2021-08-27       Impact factor: 3.240

2.  A Systematic Review of the Methodologies and Modelling Approaches Used to Generate International EQ-5D-5L Value Sets.

Authors:  Donna Rowen; Clara Mukuria; Emily McDool
Journal:  Pharmacoeconomics       Date:  2022-07-13       Impact factor: 4.558

3.  Possible Sarcopenia and Its Association with Nutritional Status, Dietary Intakes, Physical Activity and Health-Related Quality of Life among Older Stroke Survivors.

Authors:  Hui Jie Wong; Sakinah Harith; Pei Lin Lua; Khairul Azmi Ibrahim
Journal:  Ann Geriatr Med Res       Date:  2022-06-21

4.  Validation and clinical interpretation of the St George's respiratory questionnaire for COPD (SGRQ-C) after adaptation to Malaysian language and culture, in patients with COPD.

Authors:  Anees Ur Rehman; Mohamed Azmi Ahmad Hassali; Sabariah Noor Harun; Sameen Abbas; Jaya Muneswarao; Irfhan Ali Bin Hyder Ali; Rabia Hussain
Journal:  Health Qual Life Outcomes       Date:  2020-05-13       Impact factor: 3.186

5.  EQ-5D-3L health state utility values in transfusion-dependent thalassemia patients in Malaysia: a cross-sectional assessment.

Authors:  Asrul Akmal Shafie; Irwinder Kaur Chhabra; Jacqueline Hui Yi Wong; Noor Syahireen Mohammed
Journal:  Health Qual Life Outcomes       Date:  2021-01-07       Impact factor: 3.186

6.  Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension.

Authors:  Jing Wu; Shitong Xie; Xiaoning He; Gang Chen; Gengliang Bai; Da Feng; Ming Hu; Jie Jiang; Xiaohui Wang; Hongyan Wu; Qunhong Wu; John E Brazier
Journal:  Pharmacoeconomics       Date:  2021-02-18       Impact factor: 4.981

7.  The EQ-5D-5L Valuation Study in Egypt.

Authors:  Sahar A Al Shabasy; Maggie M Abbassi; Aureliano Paolo Finch; Darrin Baines; Samar F Farid
Journal:  Pharmacoeconomics       Date:  2021-03-12       Impact factor: 4.981

8.  Stroke Rehabilitation for Falls and Risk of Falls in Southeast Asia: A Scoping Review With Stakeholders' Consultation.

Authors:  Husna Ahmad Ainuddin; Muhammad Hibatullah Romli; Tengku Aizan Hamid; Mazatulfazura S F Salim; Lynette Mackenzie
Journal:  Front Public Health       Date:  2021-03-03

9.  Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol.

Authors:  Tonya Moen Hansen; Ylva Helland; Liv Ariane Augestad; Kim Rand; Knut Stavem; Andrew Garratt
Journal:  BMJ Open       Date:  2020-06-11       Impact factor: 2.692

10.  Valuation of EQ-5D-3l Health States in Slovenia: VAS Based and TTO Based Value Sets.

Authors:  Valentina Prevolnik Rupel; Andrej Srakar; Kim Rand
Journal:  Zdr Varst       Date:  2019-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.